Biotechnology and the LawAmerican Bar Association, 2007 - 957 lappuses The book is written to help lawyers faced with the challenge of identifying the legal issues and processes that must be faced by their clients in building, marketing, and protecting a biotech business. The contributors are experts in this specialized area and provide thorough, yet accessible, overviews of biotech subspecialties with an eye to practical application. A biotech legal practice involves specialized subject matter and regulatory schemes that, generally, are not part of the business lawyer's repertoire and which can present many hazards for the uninitiated. Because of the expansion in biotech practice beyond the traditional organizations and their representatives, this guide was written to help lawyers find their way through the biotech maze. |
No grāmatas satura
1.–5. rezultāts no 77.
v. lappuse
... ... d . Clinical / Regulatory 5. Employees Incubators . G. University Relationships .......... H. Early - Stage Company Agreements a . Confidentiality Agreements Company Records ........... 3. Material Transfer Contents V.
... ... d . Clinical / Regulatory 5. Employees Incubators . G. University Relationships .......... H. Early - Stage Company Agreements a . Confidentiality Agreements Company Records ........... 3. Material Transfer Contents V.
vi. lappuse
... Records ...... 124 126 .... 127 .... 132 139 140 140 140 141 142 143 3 . Who Owns What ? ( Employer v . Employee and JV Issues ) ................... 143 a . Work Made for Hire ........ 143 b . Employee Rights ......... 145 C. State Laws ...
... Records ...... 124 126 .... 127 .... 132 139 140 140 140 141 142 143 3 . Who Owns What ? ( Employer v . Employee and JV Issues ) ................... 143 a . Work Made for Hire ........ 143 b . Employee Rights ......... 145 C. State Laws ...
ix. lappuse
... Records and Reporting ........ d . Warranty .... e . Indemnification f . IP Matters ......... g . Confirmation of Ownership 3 . Patent Filing ... F. Summary Chapter V Financing a Biotech Company . William N. Wofford A. Overview ...... 1 ...
... Records and Reporting ........ d . Warranty .... e . Indemnification f . IP Matters ......... g . Confirmation of Ownership 3 . Patent Filing ... F. Summary Chapter V Financing a Biotech Company . William N. Wofford A. Overview ...... 1 ...
xiv. lappuse
... Record Keeping .... c . Implementation and Enforcement of the AWA and the AWA Regulations by the USDA Animal and Plant Health Inspection Service ( APHIS ) ...... ........................ .. 2. U.S. Government Principles for the ...
... Record Keeping .... c . Implementation and Enforcement of the AWA and the AWA Regulations by the USDA Animal and Plant Health Inspection Service ( APHIS ) ...... ........................ .. 2. U.S. Government Principles for the ...
xvii. lappuse
... Record Keeping and Reporting .... 493 3. After the Trial .............. 494 Submission and Audit 494 b . FDA Inspection .......... ..... 495 c . Administrative Actions - Civil and Criminal Penalties ................. 497 4. Preparing ...
... Record Keeping and Reporting .... 493 3. After the Trial .............. 494 Submission and Audit 494 b . FDA Inspection .......... ..... 495 c . Administrative Actions - Civil and Criminal Penalties ................. 497 4. Preparing ...
Saturs
IV | 1 |
VI | 4 |
VIII | 5 |
X | 6 |
XII | 7 |
XIV | 8 |
XVI | 9 |
XVIII | 10 |
CDLXXIV | 484 |
CDLXXVI | 485 |
CDLXXVII | 486 |
CDLXXVIII | 487 |
CDLXXIX | 488 |
CDLXXX | 489 |
CDLXXXI | 490 |
CDLXXXIV | 491 |
XX | 11 |
XXIII | 12 |
XXIV | 13 |
XXV | 25 |
XXIX | 26 |
XXXI | 28 |
XXXII | 29 |
XXXIII | 30 |
XXXIV | 31 |
XXXV | 34 |
XXXVI | 35 |
XXXVII | 38 |
XXXVIII | 39 |
XXXIX | 41 |
XL | 42 |
XLI | 43 |
XLII | 45 |
XLIII | 46 |
XLIV | 49 |
XLV | 51 |
XLVI | 52 |
XLVII | 53 |
XLVIII | 57 |
XLIX | 58 |
LI | 60 |
LII | 62 |
LIII | 63 |
LIV | 64 |
LV | 66 |
LVI | 69 |
LVII | 70 |
LVIII | 72 |
LIX | 73 |
LXII | 74 |
LXIII | 75 |
LXVI | 76 |
LXVIII | 77 |
LXX | 78 |
LXXI | 79 |
LXXIII | 80 |
LXXIV | 81 |
LXXV | 82 |
LXXIX | 83 |
LXXXII | 84 |
LXXXIII | 88 |
LXXXV | 91 |
LXXXVI | 95 |
LXXXVIII | 97 |
LXXXIX | 99 |
XCI | 100 |
XCII | 105 |
XCIII | 107 |
XCIV | 108 |
XCV | 109 |
XCVI | 110 |
XCVII | 111 |
XCIX | 112 |
CI | 113 |
CIII | 114 |
CIV | 115 |
CV | 117 |
CVI | 118 |
CVIII | 119 |
CIX | 121 |
CX | 122 |
CXI | 124 |
CXII | 126 |
CXIII | 127 |
CXIV | 132 |
CXV | 139 |
CXVIII | 140 |
CXX | 141 |
CXXI | 142 |
CXXII | 143 |
CXXIV | 145 |
CXXVI | 146 |
CXXVII | 147 |
CXXVIII | 148 |
CXXIX | 149 |
CXXX | 150 |
CXXXII | 151 |
CXXXIV | 152 |
CXXXVI | 154 |
CXXXVIII | 155 |
CXLI | 156 |
CXLIII | 158 |
CXLV | 160 |
CXLVII | 161 |
CXLVIII | 162 |
CXLIX | 168 |
CL | 169 |
CLI | 170 |
CLII | 171 |
CLIV | 172 |
CLVI | 173 |
CLVII | 174 |
CLVIII | 175 |
CLXI | 176 |
CLXVIII | 177 |
CLXXII | 178 |
CLXXVIII | 179 |
CLXXXIII | 180 |
CLXXXIV | 183 |
CLXXXVI | 184 |
CLXXXVIII | 185 |
CXC | 186 |
CXCII | 187 |
CXCV | 188 |
CXCVII | 189 |
CCII | 190 |
CCIV | 191 |
CCVI | 192 |
CCIX | 193 |
CCXIII | 194 |
CCXVIII | 195 |
CCXXII | 196 |
CCXXIII | 197 |
CCXXVII | 198 |
CCXXVIII | 199 |
CCXXX | 203 |
CCXXXI | 204 |
CCXXXIII | 206 |
CCXXXIV | 209 |
CCXXXV | 210 |
CCXXXVII | 212 |
CCXXXVIII | 213 |
CCXXXIX | 214 |
CCXLI | 215 |
CCXLIII | 216 |
CCXLIV | 217 |
CCXLV | 218 |
CCXLVII | 219 |
CCXLIX | 220 |
CCL | 221 |
CCLII | 222 |
CCLIV | 223 |
CCLVII | 224 |
CCLIX | 225 |
CCLXI | 226 |
CCLXIII | 227 |
CCLXIV | 228 |
CCLXVII | 230 |
CCLXIX | 231 |
CCLXX | 232 |
CCLXXII | 233 |
CCLXXIII | 234 |
CCLXXV | 235 |
CCLXXVII | 236 |
CCLXXVIII | 237 |
CCLXXIX | 239 |
CCLXXXI | 240 |
CCLXXXII | 241 |
CCLXXXIV | 253 |
CCLXXXV | 265 |
CCLXXXVI | 266 |
CCLXXXVII | 267 |
CCLXXXVIII | 268 |
CCLXXXIX | 270 |
CCXC | 271 |
CCXCI | 272 |
CCXCIII | 273 |
CCXCV | 274 |
CCXCVIII | 275 |
CCCII | 276 |
CCCIV | 277 |
CCCVII | 281 |
CCCX | 282 |
CCCXIII | 283 |
CCCXIV | 285 |
CCCXVI | 286 |
CCCXVII | 287 |
CCCXX | 288 |
CCCXXIII | 289 |
CCCXXVII | 290 |
CCCXXIX | 291 |
CCCXXXI | 299 |
CCCXXXIII | 300 |
CCCXXXIV | 301 |
CCCXXXVII | 302 |
CCCXXXIX | 303 |
CCCXLII | 304 |
CCCXLIV | 305 |
CCCXLVI | 307 |
CCCXLVII | 308 |
CCCXLVIII | 309 |
CCCXLIX | 310 |
CCCL | 312 |
CCCLII | 314 |
CCCLIV | 315 |
CCCLV | 318 |
CCCLVI | 325 |
CCCLVII | 326 |
CCCLVIII | 327 |
CCCLIX | 328 |
CCCLX | 330 |
CCCLXII | 331 |
CCCLXIV | 332 |
CCCLXVI | 337 |
CCCLXVII | 340 |
CCCLXVIII | 342 |
CCCLXIX | 344 |
CCCLXXI | 345 |
CCCLXXII | 346 |
CCCLXXIII | 347 |
CCCLXXIV | 348 |
CCCLXXVI | 349 |
CCCLXXVIII | 350 |
CCCLXXIX | 351 |
CCCLXXXI | 352 |
CCCLXXXIV | 353 |
CCCLXXXVII | 354 |
CCCLXXXIX | 356 |
CCCXC | 358 |
CCCXCI | 407 |
CCCXCII | 408 |
CCCXCV | 411 |
CCCXCVI | 412 |
CCCXCVII | 415 |
CCCXCVIII | 417 |
CCCXCIX | 418 |
CD | 419 |
CDI | 420 |
CDII | 421 |
CDIII | 422 |
CDIV | 423 |
CDV | 424 |
CDVIII | 425 |
CDIX | 433 |
CDX | 434 |
CDXII | 438 |
CDXIII | 439 |
CDXIV | 441 |
CDXV | 442 |
CDXVII | 445 |
CDXVIII | 446 |
CDXIX | 449 |
CDXX | 450 |
CDXXI | 451 |
CDXXII | 452 |
CDXXIII | 453 |
CDXXV | 454 |
CDXXVI | 455 |
CDXXVII | 456 |
CDXXXI | 457 |
CDXXXIV | 458 |
CDXXXVII | 459 |
CDXXXIX | 460 |
CDXLII | 461 |
CDXLIV | 462 |
CDXLVI | 463 |
CDXLIX | 464 |
CDLI | 465 |
CDLIII | 469 |
CDLVI | 470 |
CDLVIII | 471 |
CDLIX | 472 |
CDLXI | 475 |
CDLXIV | 476 |
CDLXVII | 477 |
CDLXVIII | 479 |
CDLXIX | 480 |
CDLXX | 481 |
CDLXXIII | 483 |
CDLXXXVI | 493 |
CDLXXXVII | 494 |
CDLXXXVIII | 495 |
CDLXXXIX | 497 |
CDXCI | 498 |
CDXCII | 499 |
CDXCIV | 500 |
CDXCVII | 501 |
CDXCVIII | 509 |
CDXCIX | 512 |
DI | 518 |
DII | 519 |
DIII | 521 |
DV | 523 |
DVI | 524 |
DVII | 525 |
DVIII | 526 |
DIX | 528 |
DXII | 529 |
DXV | 530 |
DXVII | 531 |
DXVIII | 532 |
DXIX | 534 |
DXXI | 536 |
DXXIII | 537 |
DXXIV | 539 |
DXXVIII | 542 |
DXXIX | 543 |
DXXX | 544 |
DXXXI | 545 |
DXXXII | 546 |
DXXXIII | 547 |
DXXXV | 549 |
DXXXVII | 550 |
DXXXVIII | 551 |
DXL | 552 |
DXLI | 553 |
DXLIII | 554 |
DXLVIII | 555 |
DL | 563 |
DLI | 564 |
DLIII | 565 |
DLV | 566 |
DLVI | 567 |
DLVIII | 568 |
DLIX | 569 |
DLX | 571 |
DLXI | 574 |
DLXIII | 576 |
DLXIV | 578 |
DLXV | 579 |
DLXVII | 580 |
DLXIX | 581 |
DLXXI | 582 |
DLXXII | 583 |
DLXXIII | 586 |
DLXXV | 587 |
DLXXVI | 588 |
DLXXVII | 591 |
DLXXVIII | 592 |
DLXXIX | 593 |
DLXXXI | 595 |
DLXXXIII | 596 |
DLXXXIV | 597 |
DLXXXV | 600 |
DLXXXVII | 602 |
DLXXXIX | 603 |
DXC | 605 |
DXCII | 607 |
DXCIII | 608 |
DXCIV | 609 |
DXCV | 610 |
DXCVIII | 612 |
DXCIX | 614 |
DC | 615 |
DCI | 623 |
DCII | 625 |
DCIII | 627 |
DCIV | 628 |
DCV | 629 |
DCVI | 630 |
DCVII | 631 |
DCVIII | 632 |
DCXI | 633 |
DCXIII | 635 |
DCXIV | 636 |
DCXV | 637 |
DCXVI | 639 |
DCXVII | 641 |
DCXVIII | 642 |
DCXX | 643 |
DCXXI | 644 |
DCXXIV | 645 |
DCXXVII | 646 |
DCXXIX | 647 |
DCXXX | 648 |
DCXXXI | 661 |
DCXXXII | 662 |
DCXXXIII | 664 |
DCXXXIV | 666 |
DCXXXV | 668 |
DCXXXVI | 670 |
DCXXXIX | 671 |
DCXLI | 672 |
DCXLIII | 673 |
DCXLIV | 674 |
DCXLV | 677 |
DCXLVI | 679 |
DCXLVIII | 680 |
DCXLIX | 682 |
DCL | 683 |
DCLII | 684 |
DCLIII | 686 |
DCLV | 687 |
DCLVI | 691 |
DCLX | 692 |
DCLXI | 693 |
DCLXII | 694 |
DCLXIV | 695 |
DCLXV | 696 |
DCLXVI | 699 |
DCLXVIII | 700 |
DCLXIX | 701 |
DCLXXI | 707 |
DCLXXII | 708 |
DCLXXIV | 709 |
DCLXXV | 710 |
DCLXXIX | 711 |
DCLXXXI | 712 |
DCLXXXIV | 713 |
DCLXXXV | 714 |
DCLXXXVI | 715 |
DCLXXXVII | 716 |
DCLXXXIX | 718 |
DCXC | 721 |
DCXCI | 722 |
DCXCII | 723 |
DCXCIV | 724 |
DCXCVII | 725 |
DCXCVIII | 726 |
DCXCIX | 728 |
DCCI | 729 |
DCCIII | 730 |
DCCV | 731 |
DCCVI | 732 |
DCCVII | 733 |
DCCVIII | 735 |
DCCXIII | 737 |
DCCXIV | 739 |
DCCXVI | 740 |
DCCXVII | 741 |
DCCXVIII | 742 |
DCCXXI | 743 |
DCCXXIII | 744 |
DCCXXIV | 745 |
DCCXXVI | 746 |
DCCXXVIII | 747 |
DCCXXIX | 748 |
DCCXXX | 749 |
DCCXXXI | 750 |
DCCXXXIII | 751 |
DCCXXXV | 753 |
DCCXXXVII | 755 |
DCCXXXVIII | 756 |
DCCXL | 757 |
DCCXLII | 758 |
DCCXLIII | 759 |
DCCXLIV | 761 |
DCCXLV | 762 |
DCCXLVI | 763 |
DCCXLVIII | 764 |
DCCLI | 765 |
DCCLII | 766 |
DCCLIII | 767 |
DCCLVI | 768 |
DCCLVII | 769 |
DCCLX | 771 |
DCCLXII | 772 |
DCCLXIII | 773 |
DCCLXV | 774 |
DCCLXVI | 775 |
DCCLXVII | 776 |
DCCLXIX | 777 |
DCCLXXI | 779 |
DCCLXXII | 780 |
DCCLXXIV | 781 |
DCCLXXVI | 782 |
DCCLXXIX | 783 |
DCCLXXXII | 784 |
DCCLXXXIII | 785 |
DCCLXXXIV | 786 |
DCCLXXXV | 787 |
DCCLXXXVI | 788 |
DCCLXXXIX | 789 |
DCCXC | 790 |
DCCXCI | 791 |
DCCXCIII | 792 |
DCCXCV | 793 |
DCCXCVIII | 794 |
DCCXCIX | 795 |
DCCCI | 796 |
DCCCV | 797 |
DCCCVI | 798 |
DCCCVIII | 813 |
DCCCIX | 815 |
DCCCX | 816 |
DCCCXII | 817 |
DCCCXIII | 818 |
DCCCXIV | 819 |
DCCCXVII | 821 |
DCCCXVIII | 822 |
DCCCXIX | 824 |
DCCCXX | 825 |
DCCCXXI | 826 |
DCCCXXII | 828 |
DCCCXXIII | 829 |
DCCCXXIV | 830 |
DCCCXXV | 831 |
DCCCXXVI | 833 |
DCCCXXVII | 834 |
DCCCXXVIII | 835 |
DCCCXXIX | 836 |
DCCCXXXI | 837 |
DCCCXXXII | 838 |
DCCCXXXIII | 840 |
DCCCXXXIV | 841 |
DCCCXXXV | 843 |
DCCCXXXVII | 857 |
DCCCXXXVIII | 858 |
DCCCXXXIX | 859 |
DCCCXLII | 863 |
DCCCXLIV | 864 |
DCCCXLV | 865 |
DCCCXLVI | 866 |
DCCCXLVII | 867 |
DCCCXLVIII | 868 |
DCCCL | 869 |
DCCCLI | 870 |
DCCCLIII | 871 |
DCCCLV | 872 |
DCCCLVI | 873 |
DCCCLVIII | 874 |
DCCCLX | 875 |
DCCCLXI | 880 |
DCCCLXIV | 881 |
DCCCLXVII | 882 |
DCCCLXX | 883 |
DCCCLXXI | 884 |
DCCCLXXIII | 885 |
DCCCLXXIV | 886 |
DCCCLXXVI | 887 |
DCCCLXXVII | 888 |
DCCCLXXVIII | 893 |
DCCCLXXIX | 894 |
DCCCLXXX | 896 |
DCCCLXXXI | 900 |
DCCCLXXXIII | 912 |
DCCCLXXXIV | 918 |
DCCCLXXXVI | 923 |
DCCCLXXXVII | 933 |
935 | |
Citi izdevumi - Skatīt visu
Biotechnology and the Law Hugh B. Wellons,Robert F. Copple,Bill Wofford Priekšskatījums nav pieejams - 2020 |
Bieži izmantoti vārdi un frāzes
addition agency agreement amended animal drugs approval authorization Bayh-Dole Act biological product biotech company biotechnology biotechnology company cell chapter claims clinical trials collaboration commercial company's compliance conduct confidentiality contract contractor Covered Entity disclose disclosure documents employee ensure European European Commission European Medicines Agency exemption FDA's federal filing founders funding genetic GMOs grant Guidance hazardous waste HIPAA human IACUC individual infringement Initial Public Offering intellectual property invention investigational investors issues license licensor limited litigation manufacturing medical devices Medicare medicinal products ment option organization parties partner patent application payment pharmaceutical pharmacovigilance potential Practice Points preclinical research prior art Privacy procedures protection registration regulations regulatory requirements risk royalty safety shares specific sponsor tion trade secret trademark VSTA